Odyssey Therapeutics (ODTX) Balance Sheet: Assets & Liabilities

Odyssey Therapeutics (ODTX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Odyssey Therapeutics reported total assets of $269.79M and total liabilities of $758.07M. Shareholders' equity was negative at −$488.28M, meaning liabilities exceed assets. Total debt stood at $27.11M against $181.36M in cash and short-term investments, a net cash position of $154.25M.

Odyssey Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Odyssey Therapeutics, Inc. (ODTX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	41.69	59.14	52.55	241.04
Short-Term Investments	139.67	70.22	134.45	-
Cash & Short-Term Investments	181.36	129.35	187.00	241.04
Accounts Receivable	0.00	-	-	-
Inventory	0.00	-	-	-
Other Current Assets	9.30	6.16	5.54	7.67
Total Current Assets	190.66	135.51	192.54	248.71
Non-Current Assets
Property, Plant & Equipment (Net)	26.01	39.47	46.73	52.77
Long-Term Investments	35.20	-	29.10	-
Goodwill	14.33	13.35	13.55	12.88
Intangible Assets	0.26	0.57	0.91	1.18
Other Non-Current Assets	3.33	8.54	3.69	1.61
Total Non-Current Assets	79.13	61.93	93.99	68.44
Total Assets	269.79	197.44	286.52	317.15
Current Liabilities
Accounts Payable	7.87	6.32	7.73	8.05
Short-Term Debt	5.21	-	-	-
Accrued Liabilities	6.25	17.52	2.44	11.39
Deferred Revenue	0.00	2.88	0.41	1.00
Other Current Liabilities	13.39	0.75	-	1.63
Total Current Liabilities	26.48	28.42	22.09	22.80
Non-Current Liabilities
Long-Term Debt	21.90	26.43	30.52	4.76
Other Non-Current Liabilities	709.69	10.22	8.41	8.20
Total Non-Current Liabilities	731.59	36.65	527.14	47.34
Total Liabilities	758.07	65.02	549.23	70.02
Stockholders' Equity
Common Stock	0.00	-	0.00	0.00
Retained Earnings	-568.14	-419.49	-289.09	-158.17
Accumulated Other Comprehensive Income	0.25	-1.34	-0.86	-2.18
Additional Paid-in Capital	79.62	38.31	27.24	15.73
Shares Outstanding	47.17	47.17	47.17	47.17
Total Stockholders' Equity	-488.28	132.41	-262.71	247.13
Total Liabilities & Equity	269.79	197.44	286.52	317.15

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Odyssey Therapeutics Balance Sheet

How much debt does Odyssey Therapeutics have?

Odyssey Therapeutics had total debt of $27.11M as of Dec 31, 2025, against $181.36M in cash and short-term investments. Total debt was $26.43M a year earlier.

What are Odyssey Therapeutics's total assets?

Odyssey Therapeutics reported total assets of $269.79M as of Dec 31, 2025, up 36.6% from $197.44M a year earlier. Total liabilities were $758.07M.

What is Odyssey Therapeutics's shareholders' equity?

Odyssey Therapeutics's shareholders' equity was negative at −$488.28M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition